title: [Screening practices for hepatitis B virus prior to viral reactivation risk therapies among different medical specialties. HEBRA Project].
authors.affiliation: Servicio de Aparato Digestivo, Hospital Donostia, San Sebastián, Gipuzkoa, España. garbengo@gmail.com
authors.forename: Manuel
authors.initials: M
authors.lastname: García-Bengoechea
authors.forename: Cándido
authors.initials: C
authors.lastname: Hernández-López
authors.forename: Javier
authors.initials: J
authors.lastname: Crespo
authors.forename: Francisco
authors.initials: F
authors.lastname: Gea
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000998:Antiviral Agents / Q000627:therapeutic use; D002983:Clinical Competence; D005260:Female; D019983:Guideline Adherence / Q000706:statistics & numerical data*; D019538:Health Care Surveys; D006509:Hepatitis B / Q000175:diagnosis* / Q000517:prevention & control / Q000821:virology; D006515:Hepatitis B virus / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D008403:Mass Screening / Q000706:statistics & numerical data*; D008511:Medicine; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D055502:Secondary Prevention; D013030:Spain; D011795:Surveys and Questionnaires; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D000970:Antineoplastic Agents; D000998:Antiviral Agents; D007166:Immunosuppressive Agents